Stocks in Motion: Marimba's Price, Volume Surge on Buyout

Updated from 12:49 p.m. EDT

Marimba ( MRBA) soared Thursday on heavy volume after the company agreed to be acquired by BMC Software ( BMC). Almost 12 million Marimba shares changed hands.

The agreement calls for BMC to buy Marimba for about $240 million , or $8.25 per share. Shares of Marimba ended the day up $3.20, or 65.7%, to $8.07. Shares of BMC, meanwhile, traded down $1.45, or 7.4%, to $18.05.

Shares of Accenture ( ACN) were active Thursday after the company priced some 50 million shares in a primary and secondary offering. An underwriting syndicate led by Morgan Stanley, UBS Investment Bank and JPMorgan placed the shares at $23.50 per share. Accenture said it plans to use the proceeds to acquire a comparable number of Accenture SCA Class I and Accenture Canada Holdings shares held by former and current partners. The new shares won't increase the number of outstanding Accenture shares.

Shares of Accenture ended the day down 1 cent, or 0.04%, to $23.75, on volume of more than 16.6 million shares.

Also active was Immune Response ( IMNR), which said that its NeuroVax drug showed strong results in phase I and II trials. NeuroVax is designed to help treat multiple sclerosis. Shares of Immune Response traded up 39 cents, or 23.9%, to $2.02 on volume of 14.7 million shares.

Other names joining the list of Nasdaq most actives included JDS Uniphase ( JDSU), Oracle ( ORCL), Microsoft ( MSFT) and Intel ( INTC).

NYSE high-volume leaders included Nortel Networks ( NT), Lucent ( LU), Time Warner ( TWX) and Texas Instruments ( TXN).

Looking at NYSE price movers, Titan International ( TWI) led the pack after saying it earned 25 cents per share on revenue of $167 million in the first quarter, 29% higher than the year-ago figure of $129 million. Shares of Titan traded up $1.14, or 16.9%, to $7.88.

PolyOne ( POL) climbed after the company said it earned 4 cents per share in the first quarter vs. a loss of 21 cents per share a year ago. Revenue rose to $535.6 million. Analysts polled by Thomson First Call were looking for the company to break even during the quarter on $486.4 million in revenue. Shares of PolyOne traded up 27 cents, or 4%, to $7.04.

Bally Total Fitness ( BFT) fell after the company announced the resignation of its chief financial officer and said that the company is the subject of a Securities and Exchange Commission accounting probe. Bally said that the SEC's focus is on its "recent restatement concerning the timing of when it recognized prepaid dues." Shares of Bally traded down 90 cents, or 16.7%, to $4.50.

Viasys Healthcare ( VAS) fell Thursday after the company announced disappointing first-quarter earnings on Wednesday evening. After excluding items, Viasys earned 12 cents per share on revenue of $95.6 million. Analysts were looking for the company to earn 21 cents per share on revenue of $100 million. Shares of Viasys traded down $3.45, or 15.4%, to $19.

Watson Pharmaceuticals ( WPI) fell after the company reported light first-quarter revenue and warned that earnings and revenue for the second quarter would not match expectations. Analysts were looking for the company to earn 54 cents per share on revenue of $424.9 million during the second quarter.

The company said that it expects to earn 50 cents to 52 cents per share on revenue of $410 million. Shares of Watson fell $5.80, or 13.6%, to $36.87.

Over on the Nasdaq, Aldila ( ALDA), a maker of golf-club shafts, rose Thursday after the company announced strong first-quarter results. The company earned 46 cents per share vs. a year-ago loss of 3 cents per share. Revenue of $15.3 million was 50% higher vs. a year ago. Shares of Aldila traded up $2.58, or 44.9%, to $8.33.

Spectranetics ( SPNC) rose Thursday after receiving clearance from the Food and Drug Administration to market one of its products. The company said the FDA's marketing clearance applies to most of the company's coronary catheters, which are used in the treatment of symptomatic ischemic peripheral vascular disease. Shares of Spectranetics traded up 43 cents, or 7.3%, to $6.30.

Mantech ( MANT) rose after the company announced first-quarter earnings of 35 cents per share on revenue of $202.8 million. Analysts were looking for the company to earn 28 cents per share on revenue of $183.8 million.

Mantech also boosted second-quarter guidance, saying earnings should come in between 32 cents and 34 cents on revenue of $204 million to $208 million. Analysts were looking for the company to earn 30 cents per share on revenue of $198 million. Shares of Mantech traded up $2.99, or 13.7%, to $24.83.

Time Warner Telecom ( TWTC) got thumped Thursday after it reported weak quarterly results. The telecom service provider reported a loss of 34 cents per share on revenue of $161.6 million during the first quarter. Analysts were looking for a loss of 27 cents per share on revenue of $164.2 million. Shares of Time Warner Telecom traded down $1.78, or 32.2%, to $3.75.

Taro Pharmaceuticals ( TARO) got slammed after it announced weaker-than-expected first-quarter results Thursday morning. The company earned 37 cents per share vs. First Call estimates of 53 cents per share. Revenue of $84.1 million was $7 million lower than analysts' expectations. Shares of Taro fell $16.88, or 27.2%, to $45.26.

VocalTec ( VOCL) fell after the company announced weak first-quarter earnings results. Its loss of 29 cents per share was significantly wider than the year-ago loss of 11 cents per share. Revenue, meanwhile, fell 81% to $1.2 million.

CEO Elon Ganor said the weak results were caused by a "continuation of extremely long sales cycles" and "delayed spending on existing network expansions from our major customers." Shares of VocalTec traded down 51 cents, or 17.1%, to $2.48.

More from Stocks

Is Tesla Really Being Sabotaged?

Is Tesla Really Being Sabotaged?

LIVE NOW: TheStreet's Top Columnists Take Your Questions on What Stocks to Buy

LIVE NOW: TheStreet's Top Columnists Take Your Questions on What Stocks to Buy

Beware of the Coming Economic Debt Bomb

Beware of the Coming Economic Debt Bomb

Dow Tumbles as Trump Ratchets Up China Trade Fight

Dow Tumbles as Trump Ratchets Up China Trade Fight

Why GE's Stock Has Fallen 15% in the Last 30 Days

Why GE's Stock Has Fallen 15% in the Last 30 Days